Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Purpose: The present study is a discovery mode proteomics analysis of the membrane‐enriched fraction of postmortem brain tissue from A lzheimer's disease (AD) and control cases. This study aims to validate a method to identify new proteins that could be involved in the pathogenesis of AD and potentially serve as disease biomarkers. Experimental design: Liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) was used to analyze the membrane‐enriched fraction of human postmortem brain tissue from five AD and five control cases of similar age. Biochemical validation of specific targets was performed by immunoblotting. Results: One thousand seven hundred and nine proteins were identified from the membrane‐enriched fraction of frontal cortex. Label‐free quantification by spectral counting and G‐test analysis identified 13 proteins that were significantly changed in disease. In addition to T au (MAPT), two additional proteins found to be enriched in AD, ubiquitin carboxy‐terminal hydrolase 1 (UCHL 1), and syntaxin‐binding protein 1 (M unc‐18), were validated through immunoblotting. Discussion and clinical relevance: Proteomic analysis of the membrane‐enriched fraction of postmortem brain tissue identifies proteins biochemically altered in AD. Further analysis of this subproteome may help elucidate mechanisms behind AD pathogenesis and provide new sources of biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“Moreover, mislocalized tau has been shown to mediate A toxicity through increased excitotoxicity [45].”
BackgroundA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568
Self-citationDaviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S., Cox, N. J., Dunbar-Jacob, J. M., Granieri, E. C., Hunt, G., McGarry, K., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00260 · Cited by 463 · cited 1×
“Moreover, it is becoming increasingly evident that the pharmacotherapy currently available may be most useful when started early in the disease course [4].”
BackgroundMaas, T., Eidenmüller, J., & Brandt, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000389200 · Cited by 226 · cited 1×
“This interaction appears to be mediated by phosphorylation; it was recently demonstrated that hyperphosphorylated tau loses its ability to bind the plasma membrane [44].”
Background
Cited by
Review: Activation patterns of microglia and their identification in the human brain
Boche, D., Perry, V. H., & Nicoll, J. A. R. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 912
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease
Bai, B., Hales, C. M., Chen, P.-C., Gozal, Y., Dammer, E. B., Fritz, J. J., Wang, X., Xia, Q., Duong, D. M., Street, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310249110 · Cited by 335
“Using subproteome studies, constituents of isolated amyloid plaques (18), AD hippocampus (19), cortical Lewy bodies (20), AD membrane fraction (21), and specific phosphorylation sites in neurofibrillary tangles (22) were identified.”
BackgroundSelf-citationBishop, P., Rocca, D., & Henley, J. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160082 · Cited by 305
Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease
Drummond, E., Nayak, S., Faustin, A., Pires, G., Hickman, R. A., Askenazi, M., Cohen, M., Haldiman, T., Kim, C., Han, X., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1691-0 · Cited by 239
Metadata
- Authors
- Donovan, L. E., Higginbotham, L., Dammer, E. B., Gearing, M., Rees, H. D., Xia, Q., Duong, D. M., Seyfried, N. T., Lah, J. J., & Levey, A. I.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2012-04
- Volume
- 6
- Issue
- 3-4
- Pages
- 201-211
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2097925533
- Cited by
- 82
- References
- 7
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease. https://app.cochat.ai/papers/10.1002/prca.201100068
- The paper
- Donovan, L. E., Higginbotham, L., Dammer, E. B., Gearing, M., Rees, H. D., Xia, Q., Duong, D. M., Seyfried, N. T., Lah, J. J., & Levey, A. I. (2012). Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.201100068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.